TB

This document reinforces the five essential elements of the DOTS strategy.

This manual provides information about the guidelines and regulations pertaining to TB infection control, methods of reducing the risk of TB infection, and facility-specific guidelines for reducing the risk and dealing with potential exposure.

The manual contains information, forms, signs, and user-friendly tools for clinics, hospitals, homeless shelters, and other parties interested in the prevention and control of tuberculosis.

This fact sheet provides general TB information for employers in non-healthcare organizations. It distinguishes between latent TB infection and active disease, describes transmission and symptoms, and gives contact information.

This publication describes Lights of Hope, a stand-alone National Tuberculosis Communication Strategy for use in Kenya in the fight against tuberculosis (TB). It is based on a study of health-seeking behaviours among Kenyans, strategy design workshops with stakeholders, and meetings with frontline TB workers. It presents a strategy for reducing the impact of TB in Kenya through communication strategies aimed at behavior change.

This manual provides information on using cohort analysis.

This brochure describes PATH's national TB programs to expand DOTS. It was created for a global meeting on TB in Paris, Oct./Nov. 2004.

The Global MDR-TB and XDR-TB Response Plan 2007-2008 sets out measures needed now to prevent, treat and control extensively drug-resistant TB (XDR-TB) and multidrug-resistant TB (MDR-TB). The plan also sets in motion actions to reach a 2015 goal of providing access to drugs and diagnostic tests to all MDR-TB and XDR-TB patients, saving the lives of up to 1.2 million patients.

This is a fact sheet for policymakers on MDR and XDR TB.

This is a fact sheet in French for policymakers on MDR and XDR TB.

This framework identifies key issues that need to be addressed to accelerate the adoption and implementation of new and improved technologies. It provides guidance on what actions are needed when improved existing and/or new medicines, diagnostics and vaccines become available.

The document identifies challenges to retooling and proposes key steps for facilitating appropriate and timely adoption and implementation. It also provides an overview of technical and operational considerations for retooling at global and national levels.